Portal de Periódicos da CAPES

A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVA

2015; Massachusetts Medical Society; Volume: 374; Issue: 17 Linguagem: Inglês

10.1056/nejmoa1411627

1533-4406

Katie Ewer, Tommy Rampling, Navin Venkatraman, Georgina Bowyer, Daniel Wright, Teresa Lambe, Egeruan B. Imoukhuede, Ruth Payne, Sarah Katharina Fehling, Thomas Strecker, Nadine Biedenkopf, Verena Krähling, Claire Maria Tully, Nick J. Edwards, Emma M. Bentley, Dhanraj Samuel, Geneviève M. Labbé, Jing Jin, Malick M. Gibani, Alice Minhinnick, Morven Wilkie, Ian Poulton, Natalie Lella, Rachel Roberts, Felicity Hartnell, Carly M. Bliss, Kailan Sierra-Davidson, Jonathan Powlson, Eleanor Berrie, Richard S. Tedder, François Roman, Iris De Ryck, Alfredo Nicosia, Nancy J. Sullivan, Daphne A. Stanley, Olivier Tshiani Mbaya, Julie E. Ledgerwood, Richard Schwartz, Loredana Siani, Stefano Colloca, Antonella Folgori, Stefania Di Marco, Riccardo Cortese, Edward Wright, Stephan Becker, Barney S. Graham, Richard A. Koup, Myron M. Levine, Ariane Volkmann, Paul Chaplin, Andrew J. Pollard, Simon J. Draper, W. Ripley Ballou, Alison M. Lawrie, Sarah C. Gilbert, Adrian V. S. Hill,

Hepatitis B Virus Studies

The West African outbreak of Ebola virus disease that peaked in 2014 has caused more than 11,000 deaths. The development of an effective Ebola vaccine is a priority for control of a future outbreak.